GLP-1 Agonists in Psoriasis & HS: What Clinicians Need to Know
GLP-1 receptor agonists are gaining attention beyond diabetes and obesity for their potential role in treating inflammatory skin and joint diseases like psoriasis, psoriatic arthritis, and hidradenitis suppurativa (HS).
Jonathan Aun, DO, FACC, FACP, is the director of noninvasive cardiovascular imaging at Brooke Army Medical Center in San Antonio, TX.
© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the The Derm APP or HMP Global, their employees, and affiliates.
Related Content
Where Dermatology APPs Learn, Lead, and Level Up.
The Derm APP is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.
The Derm APP is designed for advanced practice providers who specialize in dermatology to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods while remaining focused on the fundamental principles and terminology associated with dermatology. Engage year-round with The Derm APP to access clinical insights, interactive features, research news updates, accredited continuing-education programs, and more.
